Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Chronix Biomedical
Chronix Biomedical Says Three Recent Studies Support the Utility of Circulating DNA as Novel Diagnostics for Human Cancer, Mad Cow Disease and Other Conditions
March 24th, 2009
Chronix Biomedical - developing and applying proprietary techniques to detect and analyze circulating nucleic acid sequences for the diagnosis and management of disease - reported that three recent studies published in peer-reviewed journals have further confirmed the potential diagnostic and prognostic utility of fragments of DNA and RNA that circulate in the blood, known as circulating nucleic acids (CNAs). Data from these studies confirm previous findings showing that CNAs can identify the presence of certain diseases in blood samples months to years before clinical symptoms appear. “The recent publication of these three studies represents a major milestone in the...
Source: Cancer Weekly (2009-03-24)
|
